767 Pre-clinical and first-in-human studies of HCW9218, a bifunctional TGF-β antagonist/IL-15 protein complex, in advanced solid tumors
Main Authors: | Peter R Rhode, Hing C Wong, Jack O Egan, Jeffrey S Miller, Manish Patel, Martin Felices, Philip M Arlen, Melissa A Geller, Pallavi Chaturvedi, Shannon Lunn, Bethany Hanke, Rose Wangen, Niraj Shrestha, Danieska Sandino, Karen L Kage, Delsy G Gaetano, Giles M Leclerc, Zhu Xiaoyun, Kelsey Mullen, Deepa Kolaseri Krishnadas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice
by: Xiaoyun Zhu, et al.
Published: (2023-01-01) -
The longitudinal association between natural outdoor environments and mortality in 9218 older men from Perth, Western Australia
by: Wilma L. Zijlema, et al.
Published: (2019-04-01) -
Gasification Of Oil Palm Biomass In Hot Compressed Water (HCW) For Production Of Synthesis Gas.
by: Yong, Kelly Tau Len
Published: (2009) -
Assessing the economic effects of Hainan’s free trade port policy using the HCW method
by: Yu Haochuan
Published: (2024-01-01) -
Changing HCW attitudes: a case study of normalizing HIV service delivery in emergency departments
by: Aditi Rao, et al.
Published: (2022-05-01)